Contribution of phosphatidylinositol 3-kinase to radiation resistance in human melanoma cells

被引:0
|
作者
Krasilnikov, M
Adler, V
Fuchs, SY
Dong, Z
Haimovitz-Friedman, A
Herlyn, M
Ronai, Z
机构
[1] Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA
[2] Canc Res Ctr, Inst Carcinogenesis, Lab Tumor Biochem, Moscow, Russia
[3] Mem Sloan Kettering Canc Ctr, Dept Radiat Biol, New York, NY 10021 USA
[4] Wistar Inst, Mol & Cellular Biol Program, Philadelphia, PA 19104 USA
关键词
melanoma; phosphatidylinositol; 3-kinase; ultraviolet radiation;
D O I
10.1002/(SICI)1098-2744(199901)24:1<64::AID-MC9>3.0.CO;2-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activity of phosphatidylinositol 3-kinase (PI3K), a key component of multiple signal transduction pathways, was investigated in early- and late-stage melanoma cells that have varying degrees of radiation resistance. Analysis of PI3K biproducts (PI-3,4-P-2 and PI-3,4,5-triphosphate) revealed a direct correlation between radiation resistance and levels of PI3K activity. Treating melanoma cells with wortmanin or LY294002, two different PI3K inhibitors, decreased PI3K activity and caused a dose-dependent decrease in resistance to ultraviolet radiation. Lower resistance to radiation elicited by LY294002 coincided with increased apoptosis. To further establish the role of PI3K in radiation resistance, we transfected early-stage melanoma cells with the cDNA of p85, the regulatory subunit of PI3K. Clones that constitutively overexpressed p85 exhibited a higher degree-of PI-3,4-P-2 synthesis and a corresponding increase in their resistance to ultraviolet radiation. The results of this study point to the role of PI3K and its biproducts in radiation resistance of human melanoma cells. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:64 / 69
页数:6
相关论文
共 50 条
  • [1] PHOSPHATIDYLINOSITOL 3-KINASE
    KAPELLER, R
    CANTLEY, LC
    BIOESSAYS, 1994, 16 (08) : 565 - 576
  • [2] Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
    Miller, Todd W.
    Balko, Justin M.
    Arteaga, Carlos L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4452 - 4461
  • [3] Effects of phosphatidylinositol 3-kinase inhibitor on human cervical carcinoma cells in vitro
    Zhang Y.
    Zhang X.
    Li Y.
    Du X.
    Wang Z.
    Wang H.
    Frontiers of Medicine in China, 2009, 3 (3): : 341 - 346
  • [4] PDGF-MEDIATED ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE IN HUMAN MESANGIAL CELLS
    CHOUDHURY, GG
    BISWAS, P
    GRANDALIANO, G
    FOUQUERAY, B
    HARVEY, SA
    ABBOUD, HE
    KIDNEY INTERNATIONAL, 1994, 46 (01) : 37 - 47
  • [5] Overexpression of phosphatidylinositol 3-kinase in human lung cancer
    Xiongbin Lin
    Arnd Böhle
    Peter Dohrmann
    Ivo Leuschner
    Andreas Schulz
    Bernd Kremer
    Fred Fändrich
    Langenbeck’s Archives of Surgery, 2001, 386 : 293 - 301
  • [6] The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
    Igor Vivanco
    Charles L. Sawyers
    Nature Reviews Cancer, 2002, 2 : 489 - 501
  • [7] Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells
    Paul Brennan
    Anja M Mehl
    Matthew Jones
    Martin Rowe
    Oncogene, 2002, 21 : 1263 - 1271
  • [8] Dynamin inhibits phosphatidylinositol 3-kinase in hematopoietic cells
    Harrison-Findik, D
    Misra, S
    Jain, SK
    Keeler, ML
    Powell, KA
    Malladi, CS
    Varticovski, L
    Robinson, PJ
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2001, 1538 (01): : 10 - 19
  • [9] DISTINCT PHOSPHATIDYLINOSITOL 3-KINASE (PI 3-KINASE) ACTIVITIES FROM HUMAN-LYMPHOCYTES
    VARTICOVSKI, L
    KEELER, ML
    WU, SS
    SPRING, ME
    FASEB JOURNAL, 1992, 6 (05): : A1923 - A1923
  • [10] Role of phosphatidylinositol 3-kinase in human platelet aggregation
    Shah, B
    Saeed, SA
    Shamim, G
    Nawaz, Z
    Gilani, AH
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (04) : S600 - S600